Loading
Latest filing published 05 Jun 2019 for Pivot Pharmaceuticals Inc., €2,487.
No signal scores available.
Only one filing by Patrick Charles Frankham is known so far (5 June 2019): an open-market purchase, €2,487, in Pivot Pharmaceuticals Inc. That is too little to draw conclusions. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration